Goto A.,Depf. of Gastroenterology |
Ishimine Y.,Depf. of Gastroenterology |
Hirata T.,Depf. of Gastroenterology |
Naito T.,Depf. of Gastroenterology |
And 4 more authors.
Japanese Journal of Cancer and Chemotherapy | Year: 2014
A 61-year-old woman presented with fever and was diagnosed with choledocholithiasis, which was removed endoscopi-cally. Incidentally, a markedly elevated serum a-fetoprotein (AFP) level was detected (1,951 ng/mL), but computed tomography (CT) showed only diffuse gallbladder wall thickening. Subsequently, markedly elevated serum AFP-L3 and human chorionic gonadotropin (HCG) levels were detected (99.6% and 2,867 mlU/mL, respectively). Fluorodeoxyglucose (FDG)-positron emission tomography/CT demonstrated high FDG uptake only in the gallbladder. Gallbladder cancer was suspected and the patient was scheduled for a cholecystectomy. However, CT just prior to surgery revealed multiple liver metastases. Percutaneous gallbladder biopsy revealed a moderately differentiated adenocarcinoma positive for AFP but not HCG. The patient underwent chemotherapy consisting of gemcitabine and cisplatin. A CT scan obtained 12 weeks later showed disease progression and AFP and HCG levels were found to have increased to 4,021 ng/mL and 66,000 mlU/mL, respectively. Although immunohistochemistry of biopsy specimen did not demonstrate HCG production, increased serum HCG level on disease progression definitely suggested HCG production of gallbladder cancer. We believe the biopsy specimen was very small and therefore did not prove HCG production. Gallbladder cancer with simultaneous production of AFP and HCG is rare, and we therefore report this case together with a review of the literature.